Dr Guillermo Carvajal AlegriaRhumatologue à Chambray-lès-Tours

Praticien hospitalier

Appeler· 02 47 47 47 47 Rechercher sur Doctolib

Guillermo CARVAJAL ALEGRIA 04/09/2024 Traitements d'épargne en corticoïdes dans l'ACG et la PPRCOFER

Photo : Havang(nl), CC0, Wikimedia Commons

Dans les médias

COFER

Vous êtes Dr Guillermo Carvajal Alegria ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.

Configurer votre fiche gratuitement →

Dr Guillermo Carvajal Alegria est rhumatologue à Chambray-lès-Tours (37170). Il consulte à CHRU TROUSSEAU - CHAMBRAY, Avenue DE LA REPUBLIQUE, 37170 Chambray-lès-Tours.

Enregistrer le contact

publications: 50publications
citations: 1 257citations
vidéo: 1vidéo

Consulter

Lieu de consultation

CHRU TROUSSEAU - CHAMBRAY
Avenue DE LA REPUBLIQUE, 37170 Chambray-lès-Tours

Dr Guillermo Carvajal Alegria, c'est vous ?

Faites de cette fiche la page de votre cabinet.

Votre présentationQuelques lignes sur votre pratique, affichées en tête de page.
Vos domaines d'expertiseLes pathologies que vous suivez, à la place des domaines déduits.
Vos actesÉchographie, infiltrations, viscosupplémentation, PRP, téléexpertise.
Vos liensSite du cabinet, LinkedIn, secteur de conventionnement corrigé.

Configurer votre fiche gratuitementGratuit · réservé au praticien

Formation

Parcours et diplômes (11)

DES

DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées

CES

DE Docteur en médecine · DIU Etudes approfondies polyarthrites-maladies — Capacité / certificat d'études spéciales

DIU Études approfondies polyarthrites & maladies auto-immunes

Le DIU rhumato généraliste de référence : polyarthrite rhumatoïde, spondyloarthrite, lupus, Sjögren, vascularites. Coordonné par la SFR.

Plusieurs universités, coordination Société Française de Rhumatologie (SFR)

2021–2026
Université de Tours
2024–2026
Centre National de la Recherche Scientifique
2021–2026
Centre Hospitalier Universitaire de Tours
2024–2026
Centre de Biophysique Moléculaire
2025
Inserm
2023
Universitätsmedizin Göttingen
Affiliations déclarées dans les publications (OpenAlex).

En bref

Questions fréquentes sur Dr Guillermo Carvajal Alegria

Où consulte Dr Guillermo Carvajal Alegria ?

Dr Guillermo Carvajal Alegria consulte à CHRU TROUSSEAU - CHAMBRAY, Avenue DE LA REPUBLIQUE, 37170 Chambray-lès-Tours. Adresses issues de l'Annuaire Santé (ANS).

Comment prendre rendez-vous avec Dr Guillermo Carvajal Alegria ?

Par téléphone au 02 47 47 47 47 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.

D'où viennent les informations de cette page ?

Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.

Polymyalgia rheumatica · 13

2025Arthritis & rheumatology (Hoboken, N.J.)PubMed

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica

2025Joint bone spinePubMed

The role of senescence in polymyalgia rheumatica and giant cell arteritis

2025The Lancet. RheumatologyPubMed

Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial

2024Autoimmunity reviewsPubMed

The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials

2024RMD openPubMed

Concordance and agreement between different activity scores in polymyalgia rheumatica

2023The Lancet. RheumatologyPubMed

Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial

2023Frontiers in immunologyPubMed

Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?

2022JAMAPubMed

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial

2021Rheumatology and therapyPubMed

Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade

2021Joint bone spinePubMed

Tocilizumab controls bone turnover in early polymyalgia rheumatica

2020Autoimmunity reviewsPubMed

The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle

2020Seminars in arthritis and rheumatismPubMed

Is Tocilizumab as efficient as steroids early in polymyalgia rheumatica?

2017Rheumatology (Oxford, England)PubMed

Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica

Biothérapies non-anti-TNF · 9

2025Arthritis & rheumatology (Hoboken, N.J.)PubMed

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica

2023The Lancet. RheumatologyPubMed

Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial

2022JAMAPubMed

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial

2021Journal of immunology (Baltimore, Md. : 1950)PubMed

Abatacept Promotes Regulatory B Cell Functions, Enhancing Their Ability to Reduce the Th1 Response in Rheumatoid Arthritis Patients through the Production of IL-10 and TGF-β

Polyarthrite rhumatoïde · 9

2026Joint bone spinePubMed

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry

2023Rheumatology (Oxford, England)PubMed

Prevalence and predictors of atlanto-axial subluxation in rheumatoid arthritis after 12-years' follow-up (ESPOIR Cohort)

2023Inflammation research : official journal of the European Histamine Research Society ... [et al.]PubMed

Efficacy of Janus kinase inhibitors in rheumatoid arthritis

2023Clinical and experimental rheumatologyPubMed

Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort

Sjögren · 9

2025Rheumatology (Oxford, England)PubMed

Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study

2024RMD openPubMed

Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease

2024Rheumatology and therapyPubMed

Reliability Exercise of Ultrasound Salivary Glands in Sjögren's Disease: An International Web Training Initiative

2023Joint bone spinePubMed

Diagnostic utility of a second minor salivary gland biopsy in patients with suspected Sjögren's syndrome: A retrospective cohort study

Maladie de Horton · 7

2026Joint bone spinePubMed

Future options in the treatment of giant cell arteritis

2025Joint bone spinePubMed

The role of senescence in polymyalgia rheumatica and giant cell arteritis

2025La Revue de medecine internePubMed

Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

2025La Revue de medecine internePubMed

French protocol for the diagnosis and management of giant cell arteritis

Transversal · 6

2026Joint bone spinePubMed

Novel tools for targeted therapies in difficult-to-treat rheumatic diseases

2025Human gene therapyPubMed

Autologous Production: The Future of Sustainable Antibody Treatments

2023Clinical and experimental rheumatologyPubMed

Towards a universal definition of disease activity score thresholds: the AS135 score

2020Rheumatology (Oxford, England)PubMed

A simplified radiographic score effectively predicts radiographic progression of early arthritis in a large nationwide French cohort

Spondyloarthrite · 4

2022BMC musculoskeletal disordersPubMed

Hip Pain Associated with Acetabular Dysplasia in Patients with Suspected Axial Spondyloarthritis: DESIR Cohort Data

2020Rheumatology (Oxford, England)PubMed

Association of lumbosacral transitional vertebra and sacroiliitis in patients with inflammatory back pain suggesting axial spondyloarthritis

2020Seminars in arthritis and rheumatismPubMed

Associations of lumbar scoliosis with presentation of suspected early axial spondyloarthritis

2020Rheumatology (Oxford, England)PubMed

Spinal-pelvic orientation: potential effect on the diagnosis of spondyloarthritis

Vascularites · 3

2025La Revue de medecine internePubMed

Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

2018Autoimmunity reviewsPubMed

Anti-neutrophil cytoplasmic antibody-associated chronic inflammatory arthritis without vasculitis. Data from a French nationwide survey

2016Joint bone spinePubMed

New onset of rheumatoid vasculitis during abatacept therapy and subsequent improvement after rituximab

Échographie · 2

2021Rheumatology (Oxford, England)PubMed

Salivary gland ultrasonography in primary Sjögren's syndrome: opportunities and challenges

2019Joint bone spinePubMed

Assessment of major salivary gland size in primary Sjögren's syndrome: Comparison between clinical examination and ultrasonography

JAK inhibiteurs · 2

2026Joint bone spinePubMed

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry

2025The Lancet. RheumatologyPubMed

Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial

csDMARDs · 1

2024Rheumatology and therapyPubMed

Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy

Maladie à IgG4 · 1

2016Annals of the rheumatic diseasesPubMed

Could abatacept directly target expanded plasmablasts in IgG4-related disease?

Revue générale · 1

2017Clinical reviews in allergy & immunologyPubMed

Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Rhumatisme psoriasique · 1

2024Rheumatology and therapyPubMed

Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy

Dr Guillermo Carvajal AlegriaRhumatologue à Chambray-lès-Tours

Lieu de consultation

Préparer votre rendez-vous

Conventionnement et remboursement

Expertise et points clés

Parcours et diplômes (11)

Travaux scientifiques (59)

Vidéos et presse (1)

Questions fréquentes sur Dr Guillermo Carvajal Alegria

Où consulte Dr Guillermo Carvajal Alegria ?

Comment prendre rendez-vous avec Dr Guillermo Carvajal Alegria ?

D'où viennent les informations de cette page ?

Rhumatologues à Chambray-lès-Tours et alentours